Influence of Rex and intronic sequences on expression of spliced mRNAs produced by human T cell leukemia virus type I

AIDS Research and Human Retroviruses

Volumn 15, Issue 15, 1999, Pages 1351-1363

  D'Agostino, Donna M ^a   Ciminale, Vincenzo ^a   Zotti, Lorenza ^a   Chieco Bianchi, Luigi ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; MESSENGER RNA; PROTEIN P21; REX PROTEIN;

ARTICLE; ENHANCER REGION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; INTRON; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RNA SEQUENCE; VIRUS EXPRESSION;

EID: 0033544029     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299310061     Document Type: Article

References (56)

1. Cann AJ and Chen ISY: Human T-cell leukemia virus types I and II. In: Fields Virology, (Fields BN, et al., eds.), 3rd Ed. Raven Press, New York, 1996, pp. 1849-1880.
2. Rabson AB and Graves BJ: Synthesis and processing of viral RNA. In: Retroviruses (Coffin JM, et al., eds.). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1997, pp. 205-261.
3. Seiki M, Hattori S, Hirayama Y, and Yoshida M: Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci USA 1983;80:3618-3622.
4. Seiki M, Hikikoshi A, Taniguehi T, and Yoshida M: Expression of the pX gene of HTLV-I: General splicing mechanism in the HTLV family. Science 1985;228:1532-1534.
5. Hattori D, Kiyokawa T, Inakawa K, Shimizu F, Hashimura E, Seiki M, and Yoshida M: Identification of gag and env gene products of human T-cell leukemia virus (HTLV). Virology 1984;136:338-347.
6. x and two other phosphoproteins. J Virol 1986;60:394-399.
7. Furukawa K, Furukawa K, and Shiku H: Spliced mRNA of the pX region of human T lymphotropic virus type I proviral genome. FEBS Lett 1991;295:141-145.
8. Orita S, Saiga A, Takagi S, Takanka T, Okumura K, Aono Y, Hinuma Y, and Igarashi H: A novel alternatively spliced viral mRNA transcribed in cells infected with human T-cell leukemia virus type I is mainly responsible for expressing p21X protein. FEBS Lett 1991;295:127-134.
9. Bhat NK, Adachi Y, Samuel KP, and Derse D: HTLV-I gene expression by defective proviruses in an infected T-cell line. Virology 1993;196:15-24.
10. Berneman ZN, Gartenhaus RB, Reitz MS, Blattner WA, Manns A, Hanchard B, Ikehara O, Gallo RC, and Klotman ME: Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. Proc Natl Acad Sci USA 1992;89:3005-3009.
11. x protein. Virology 1996;220:502-507.
12. Ciminale V, Pavlakis GN, Derse D, Cunningham CP, and Felber BF: Complex splicing in the HTLV family of retroviruses: Novel mRNAs and proteins produced by HTLV-1. J Virol 1992;66: 1737-1745.
13. Koralnik IJ, Gessain A, Klotman ME, Lo Monico A, Berneman ZN, and Franchini G: Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I. Proc Natl Acad Sci USA 1992;89:8813-8817.
14. Franchini G: Molecular mechanisms of human T-cell leukemia/ lymphotropic virus type I infection. Blood 1995;86:3619-3639.
15. Yoshida M: Multiple targets of HTLV-I for dysregulation of host cells. Semin Virol 1996;7:349-360.
16. Parslow TG: Post-transcriptional regulation of human retroviral gene expression. In: Human Retroviruses (Cullen BR, ed.). Oxford University Press, New York, 1993, pp. 101-136.
17. Seiki M, Inoue J-I, Hidaka M, and Yoshida M: Two cis-acting elements responsible for posttranscriptional trans-regulation of gene expression of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 1988;85:7124-7128.
18. x-III of HTLV-I is required for gag gene expression. FEBS Lett 1986;209:187-190.
19. Inoue J, Yoshida M, and Seiki M: Transcriptional (p40x) and post-transcriptional p27x-III regulators are required for the expression and replication of human T-cell leukemia virus type I genes. Proc Natl Acad Sci USA 1987;84:3653-3657.
20. Hidaka M, Inoue J, Yoshida M, and Seiki M: Post-transcriptional regulator (rex) of HTLV-I initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J 1988;7:519-523.
21. Gröne M, Koch C, and Grassmann R: The HTLV-1 Rex protein induces nuclear accumulation of unspliced RNA by avoiding intron excision and degradation. Virology 1996;218:316-325.
22. Seiki M, Hikioshi A, and Yoshida M: The U5 sequence is a cis-acting repressive element for genomic RNA expression of human T cell leukemia virus type I. Virology 1990;176:81-86.
23. King JA, Bridger JM, Lochelt M, Lichter P, Schultz TF, Schirrmacher V, and Khazaie K: Nucleocytoplasmic transport of HTLV-1 RNA is regulated by two independent LTR encoded nuclear retention elements. Oncogene 1998;16:3309-3316.
24. D'Agostino DM, Ciminale V, Zotti L, Rosato A, and Chieco-Bianchi L: The human T-cell lymphotropic virus type 1 Tof protein contains a bipartite nuclear localization signal that is able to functionally replace the amino-terminal domain of Rex. J Virol 1997;71:75-83.
25. Schwartz S, Felber BK, Benko DM, Fenyö EM, and Pavlakis GN: Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J Virol 1990;64: 2519-2529.
26. Graham FJ and Van der Eb AJ: A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973;52:456-460.
27. Derse D, Mikovits J, Polianova M, Felber BK, and Ruscetti F: Virions released from cells transfected with a molecular clone of human T-cell leukemia virus type I give rise to primary and secondary infections of T cells. J Virol 1995;69:1907-1912.
28. Ciminale V, D'Agostino DM, Zotti L, Franchini G, Felber BK, and Chieco-Bianchi L: Expression and characterization of proteins produced by mRNAs spliced into the X region of the human T-cell leukemia/lymphotropic virus type II. Virology 1995;209:445-456.
29. Zolotukhin AS, Valentin A, Pavlakis GN, and Felber BK: Continuous propagation of RRE(-) and Rev(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes. J Virol 1994;68:7944-7952.
30. Mermer B, Felber BK, Campbell M, and Pavlakis GN: Identification of trans-dominant HIV-1 protein mutants by direct transfer of bacterially produced proteins into human cells. Nucleic Acid Res 1990;18:2037-2044.
31. Solomin L, Felber BK, and Pavlakis GN: Different sites of interaction for Rev, Tev, and Rex proteins within the rev responsive element of human immunodeficiency virus type 1. J Virol 1990;64: 6010-6017.
32. Hanly SM, Rimsky LT, Malim MH, Kim JH, Hauber J, Dodon MD, Le S-Y, Maizel JV, Cullen BR, and Greene WC: Comparative analysis of the HTLV-I Rex and HIV-1 Rev transregulatory proteins and their RNA response elements. Genes Dev 1989;3: 1534-1544.
33. Toyoshima H, Itoh M, Inoue J-I, Seiki M, Takaku F, and Yoshida M: Secondary structure of the human T-cell leukemia virus type I rex-responsive element is essential for rex regulation of RNA processing and transport of unspliced RNAs. J Virol 1990;64:2825-2832.
34. Ohtani K, Nakamura M, Saito S, Noda T, Ito Y, Sugamura K, and Hinuma Y: Identification of two distinct elements in the long terminal repeat of HTLV-I responsible for maximum gene expression. EMBO J 1987;6:389-395.
35. Nakamura M, Ohtani K, Hinuma Y, and Sugamora K: Functional mapping of the activity of the R region in the human T-cell leukemia virus long terminal repeat to increase gene expression. Virus Genes 1988;2:147-155.
36. Takebe Y, Seiki M, Fujisawa J-I, Hoy P, Yokota K, Arai K-I, Yoshida M, and Arai N: SRa promoter: An efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol Cell Biol 1988;8:466-472.
37. Derse D and Casey JW: Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression. Science 1986;231:1437-1440.
38. Kashanchi F, Duvall JF, Lindholm PF, Radonovich MF, and Brady JN: Sequences downstream of the RNA initiation site regulation human T cell lymphotropic virus type I basal gene expression. J Virol 1993;67:2894-2902.
39. Kashanchi F, Duvall JF, Dittmer J, Mireskandari A, Reid RL, Gitlin SD, and Brady JN: Involvement of the transcription factor YB-1 in human T-cell lymphotropic virus type I basal gene expression. J Virol 1994;68:561-565.
40. Bray M, Prasad S, Dubay JW, Hunter E, Jeang K-T, Rekosh D, and Hammerskjold M-L: A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc Natl Acad Sci USA 1994;91:1256-1260.
41. Rizvi TA, Schmidt RD, Lew KA, and Keeling ME: Rev/RRE-independent Mason-Pfizer monkey virus constitutive transport element-dependent propagation of SIVmac239 vectors using a single round of replication assay. Virology 1996;222:457-463.
42. Saavedra C, Felber BK, and Izaurralde E: The simian retrovirus-1 constitutive transport element, unlike the HIV-1 RRE, uses factors required for cellular mRNA export. Curr Biol 1997;7:619-628.
43. Pasquinelli AE, Ernst RK, Lund E, Grimm C, Zapp ML, Rekosh D, Hammarskjold ML, and Dahlberg JE: The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway. EMBO J 1997;16:7500-7510.
44. Huang MTF and Gorman CM: Intervening sequences increase efficiency of RNA 3′ processing and accumulation of cytoplasmic RNA. Nucleic Acids Res 1990;18:937-947.
45. Ryu W-S and Mertz JE: Simian virus 40 late transcripts lacking excisable intervening sequences are defective in both stability in the nucleus and transport to the cytoplasm. J Virol 1989;63: 4386-4394.
46. Buchman AR and Berg P: Comparison of intron-dependent and intron-independent gene expression. Mol Cell Biol 1988;8:4395-4404.
47. Nakielny S, Fischer U, Michael WM, and Dreyfuss G: RNA transport. Annu Rev Neurosci 1997;20:269-301.
48. Lu X, Heimer J, Rekosh D, and Hammarskjold M-L: U1 small nuclear RNA plays a direct role in the formation of a Rev-regulated human immunodeficiency virus env mRNA that remains unspliced. Proc Natl Acad Sci USA 1990;87:7598-7602.
49. Niwa M, Rose SD, and Berget SM: In vitro polyadenylation is stimulated by the presence of an upstream intron. Genes Dev 1990;4: 1552-1559.
50. Decker CJ and Parker R: A turnover pathway for both stable and unstable mRNA in yeast: evidence for a requirement for deadenylation. Genes Dev 1993;7:1632-1643.
51. Eckner R, Ellmeier W, and Birnstiel ML: Mature mRNA 3′ end formation stimulates RNA export from the nucleus. EMBO J 1991;10:3513-3522.
52. Legrain P and Roshbash M: Some cis-and trans-acting mutants for splicing target pre-mRNA to the cytoplasm. Cell 1989;57:573-583.
53. Felber BK: Posttranscriptional control: A general and important regulatory feature of HIV-1 and other retroviruses. In: Viral Regulatory Structures and Their Degeneracies (Myers G, ed.), Proc. Vol. XXVIII. Addison Wesley, Reading, Massachusetts, 1998, pp. 101-122.
54. Chang DD and Sharp PA: Regulation by HIV Rev depends upon recognition of splice sites. Cell 1989;59:789-795.
55. Rizvi TA, Schmidt RD, and Lew KA: Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) functions in a position-dependent manner. Virology 1997;236:118-129.
56. Hamaia S, Cassé H, Gazzolo L, and Due Dodon M: The human T-cell leukemia virus type 1 Rex regulatory protein exhibits an impaired functionality in human lymphoblastoid Jurkat T cells. J Virol 1997;71:8514-8521.